MORTON GROVE, Ill.--(BUSINESS WIRE)--Regis Technologies, Inc., a leading provider of cGMP and non-GMP synthesis and separations services for active pharmaceutical ingredients that help expedite drugs to market, announced today that it has expanded its scientific staff with the addition of four scientists formerly employed by deCODE genetics Inc., which filed this month for Chapter 11 protection in U.S. Bankruptcy Court.
